Endometrial Cancer
Studies from University of Helsinki yield new information about endometrial cancer
Published in Drug Law Weekly, January 19th, 2010
In this recent study, researchers in Helsinki, Finland conducted a study "To estimate the risk of endometrial cancer in all Finnish postmenopausal women using various forms of estradiol-progestin therapy. All Finnish women (aged more than 50 years) who had used estradiol-progestin therapy in 1994-2006 for at least 6 months (n=224,015) were identified from the national medical Reimbursement Registry and linked to the Finnish Cancer Registry."
"A total of 1,364 type I and 38 type 11 endometrial cancers were recorded by the end of 2006. The incidence of endometrial cancer in estradiol-progestin therapy users was compared with that in the general population in this cohort...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2010-01-19)
More Articles from Drug Law Weekly
- Adventrx Pharmaceuticals, Inc.
ADVENTRX Pharmaceuticals Announces Closing of Financing - Anemia
Study results from University of California provide new insights into anemia - Bartell Drugs
Bartell Drugs Cites Reduced Compensation by the State of Washington; Discontinues Filling DSHS/Medicaid Prescriptions at 15 Locations - Behavioral Innovations
First Autism Treatment Center in Dallas to Provide Insurance Relief for Parents - Biopharmaceuticals
Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Effic - Boomerang Systems, Inc.
Boomerang Systems, Inc. Elects Steven C. Rockefeller, Jr. to the Board of Directors - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
